Liangquan Geng

536 total citations
43 papers, 320 citations indexed

About

Liangquan Geng is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Liangquan Geng has authored 43 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 16 papers in Oncology and 9 papers in Genetics. Recurrent topics in Liangquan Geng's work include Hematopoietic Stem Cell Transplantation (32 papers), Acute Myeloid Leukemia Research (16 papers) and Polyomavirus and related diseases (10 papers). Liangquan Geng is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Acute Myeloid Leukemia Research (16 papers) and Polyomavirus and related diseases (10 papers). Liangquan Geng collaborates with scholars based in China, Australia and Canada. Liangquan Geng's co-authors include Zimin Sun, Huilan Liu, Baolin Tang, Changcheng Zheng, Juan Tong, Xiaoyu Zhu, Xiucai Xu, Aimei Zhang, Yuanyuan Shen and Yiping Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Liangquan Geng

38 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liangquan Geng China	11	238	107	107	67	44	43	320
Johan Törlén Sweden	10	224 0.9×	76 0.7×	115 1.1×	48 0.7×	43 1.0×	16	307
L-P Xu China	10	354 1.5×	96 0.9×	164 1.5×	84 1.3×	52 1.2×	14	400
Sameh Ayari France	12	232 1.0×	144 1.3×	71 0.7×	71 1.1×	37 0.8×	23	345
Hee‐Je Kim South Korea	10	159 0.7×	75 0.7×	89 0.8×	48 0.7×	70 1.6×	38	280
Sally Mokhtari United States	9	221 0.9×	72 0.7×	72 0.7×	58 0.9×	87 2.0×	31	286
Gao Zy China	3	299 1.3×	85 0.8×	148 1.4×	85 1.3×	32 0.7×	3	352
Lan‐Ping Xu China	2	379 1.6×	119 1.1×	178 1.7×	97 1.4×	43 1.0×	5	414
Han‐Seung Park South Korea	9	252 1.1×	75 0.7×	128 1.2×	67 1.0×	44 1.0×	43	347
Zhengzheng Fu China	10	164 0.7×	85 0.8×	55 0.5×	80 1.2×	27 0.6×	41	269
M. Schaffer Sweden	6	238 1.0×	63 0.6×	159 1.5×	40 0.6×	63 1.4×	8	335

Countries citing papers authored by Liangquan Geng

Since Specialization

Citations

This map shows the geographic impact of Liangquan Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangquan Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangquan Geng more than expected).

Fields of papers citing papers by Liangquan Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangquan Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangquan Geng. The network helps show where Liangquan Geng may publish in the future.

Co-authorship network of co-authors of Liangquan Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Liangquan Geng. A scholar is included among the top collaborators of Liangquan Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangquan Geng. Liangquan Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wenya, Liangquan Geng, Xinyi Zhang, et al.. (2023). Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation. Frontiers in Immunology. 14. 1084901–1084901. 4 indexed citations

Wang, Li, Na Zhao, Li Zhou, et al.. (2022). Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study. SHILAP Revista de lepidopterología. 1 indexed citations

Xue, Lei, Hui Xu, Liangquan Geng, et al.. (2022). Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells. Frontiers in Immunology. 13. 879030–879030. 1 indexed citations

Wang, Shaochen, Dongyao Wang, Yu‐Ting Chang, et al.. (2022). Elevated RAP1A expression correlates with the severity of acute GVHD after umbilical cord blood transplantation. Transplant Immunology. 71. 101546–101546.

Tong, Juan, Na Zhao, Xing Hu, et al.. (2021). Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting. Cancer Management and Research. Volume 13. 5613–5621. 8 indexed citations

Sun, Guangyu, Baolin Tang, Mei‐Juan Tu, et al.. (2021). Chimeric Antigen Receptor T Cell Therapy followed by Unrelated Cord Blood Transplantation for the Treatment of Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia in Children and Young Adults: Superior Survival but Relatively High Post-Transplantation Relapse. Transplantation and Cellular Therapy. 28(2). 71.e1–71.e8. 5 indexed citations

Li, Guifang, Zimin Sun, Liangquan Geng, et al.. (2021). Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning. Pediatric Transplantation. 26(2). e14181–e14181. 1 indexed citations

Zhu, Xiaoyu, Baolin Tang, Liangquan Geng, et al.. (2020). Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1372–1381.

Lee, Jongbok, Siqi Cheng, Dongyao Wang, et al.. (2020). Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial. Blood. 136(Supplement 1). 1–2. 14 indexed citations

10.

Zhu, Xiaoyu, Lulu Huang, Changcheng Zheng, et al.. (2017). European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 23(12). 2118–2126. 10 indexed citations

11.

Zheng, Changcheng, Baolin Tang, Xiaoyu Zhu, et al.. (2016). Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG. Annals of Hematology. 96(1). 115–124. 10 indexed citations

12.

Zheng, Changcheng, Xiaoyu Zhu, Baolin Tang, et al.. (2014). Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia. Annals of Hematology. 94(3). 473–480. 22 indexed citations

13.

Zhang, Miao, et al.. (2013). Clinical Characteristics of Patients With Infectious Complications Following Umbilical Cord Blood Transplantation. 36(3). 193–197. 1 indexed citations

14.

Sun, Zimin, Huilan Liu, Liangquan Geng, et al.. (2013). Primary research on unrelated double umbilical cord blood transplantation and implantation kinetics. Hematology. 18(5). 253–259. 4 indexed citations

15.

Tong, Juan, et al.. (2013). [Analysis of the therapeutic effect and safety of diagnosis and treatment regimen in Chinese adult patients with acute lymphoblastic leukemia--the comparative study of one single centre].. PubMed. 34(4). 349–52. 1 indexed citations

16.

Zheng, Changcheng, Baolin Tang, Juan Tong, et al.. (2013). Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia. Annals of Hematology. 92(12). 1665–1673. 5 indexed citations

17.

Wang, Xingbing, Huilan Liu, Liangquan Geng, et al.. (2011). Pre‐engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies. European Journal Of Haematology. 88(1). 39–45. 26 indexed citations

18.

Liu, Huilan, Xingbing Wang, Liangquan Geng, et al.. (2009). Successful second transplantation with non-myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation. Pediatric Transplantation. 14(4). 465–470. 5 indexed citations

19.

Zhou, Miao, Zimin Sun, Huilan Liu, et al.. (2009). Engraftment Kinetics After Transplantation of Double Units of Umbilical Cord Blood From Unrelated Donors in Adolescents and Adults with Hematologic Malignancies.. Blood. 114(22). 1183–1183. 2 indexed citations

20.

Sun, Zimin, et al.. (2009). [Reconstitution of NK cells and their receptors in patients with acute leukemia following unrelated cord blood stem cell transplantation].. PubMed. 17(2). 426–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact